CLINICAL STUDIES

SHIELD™ LUNG Study


If you plan to undergo or are undergoing screening for lung cancer, the SHIELD LUNG Study may be for you.


Supporting the Detection of Lung Cancer

Cancer screening is an effective way to detect cancer early, when it can most easily be treated. Unfortunately, many people today are not being screened in line with medical guideline recommendations.

At Guardant Health, we believe a simple blood test can improve lung cancer screening compliance by overcoming barriers associated with current methods, such as low-dose CT scans, while still being effective and more accessible.

To accomplish these objectives, Guardant Health is leveraging data from the tens of thousands of cancer patients it has already tested, as well as collaborating with multiple investigators at cancer centers around the world.

Guardant Health is addressing this shortcoming by developing a blood test that seeks to increase screening rates and overcome the challenges of current methods, all from a simple blood draw.

For More information visit ClinicalTrials.gov or Contact us.